Choosing Breast Cancer Risk Models: Importance of Independent Validation

被引:10
作者
Gail, Mitchel H. [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2020年 / 112卷 / 05期
基金
美国国家卫生研究院;
关键词
WOMEN; SUSCEPTIBILITY; PROBABILITIES; PREVENTION; TAMOXIFEN;
D O I
10.1093/jnci/djz180
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:433 / 435
页数:3
相关论文
共 24 条
  • [1] The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
    Antoniou, A. C.
    Cunningham, A. P.
    Peto, J.
    Evans, D. G.
    Lalloo, F.
    Narod, S. A.
    Risch, H. A.
    Eyfjord, J. E.
    Hopper, J. L.
    Southey, M. C.
    Olsson, H.
    Johannsson, O.
    Borg, A.
    Passini, B.
    Radice, P.
    Manoukian, S.
    Eccles, D. M.
    Tang, N.
    Olah, E.
    Anton-Culver, H.
    Warner, E.
    Lubinski, J.
    Gronwald, J.
    Gorski, B.
    Tryggvadottir, L.
    Syrjakoski, K.
    Kallioniemi, O-P
    Eerola, H.
    Nevanlinna, H.
    Pharoah, P. D. P.
    Easton, D. F.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (08) : 1457 - 1466
  • [2] CHOUDHURY H, 2020, JNCI-J NATL CANCER I, V112
  • [3] CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO
  • [4] 2-5
  • [5] Validation studies for models projecting the risk of invasive and total breast cancer incidence
    Costantino, JP
    Gail, MH
    Pee, D
    Anderson, S
    Redmond, CK
    Benichou, J
    Wieand, HS
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (18) : 1541 - 1548
  • [6] Cuzick J, 2019, LANCET ONCOL, V20, P504
  • [7] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
    Fisher, B
    Costantino, JP
    Wickerham, DL
    Redmond, CK
    Kavanah, M
    Cronin, WM
    Vogel, V
    Robidoux, A
    Dimitrov, N
    Atkins, J
    Daly, M
    Wieand, S
    Tan-Chiu, E
    Ford, L
    Wolmark, N
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) : 1371 - 1388
  • [8] Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older
    Freedman, Andrew N.
    Yu, Binbing
    Gail, Mitchell H.
    Costantino, Joseph P.
    Graubard, Barry I.
    Vogel, Victor G.
    Anderson, Garnet L.
    McCaskill-Stevens, Worta
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) : 2327 - 2333
  • [9] PROJECTING INDIVIDUALIZED PROBABILITIES OF DEVELOPING BREAST-CANCER FOR WHITE FEMALES WHO ARE BEING EXAMINED ANNUALLY
    GAIL, MH
    BRINTON, LA
    BYAR, DP
    CORLE, DK
    GREEN, SB
    SCHAIRER, C
    MULVIHILL, JJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) : 1879 - 1886
  • [10] Gail MH, 2019, LANCET ONCOL, V4